pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

Federal AI Initiative Aims to Improve Chronic Heart Failure Care, Pending Doctor and Patient Acceptance

Sep 22, 2026·read at Endpoints ↗Neutral

A new federal program will test artificial‑intelligence tools in the management of chronic heart‑failure patients. The initiative is designed to explore how AI can support diagnosis, monitoring and treatment decisions in a real‑world setting.

Proponents say AI could help clinicians spot early signs of decompensation, personalize medication regimens and reduce hospital readmissions. However, the program’s impact will hinge on whether doctors and patients are willing to trust and adopt the technology.

The experiment is still in its early stages, with no firm timeline for broader rollout. If successful, the approach could be extended to other chronic conditions, potentially reshaping long‑term care in the United States.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “A federal AI experiment could transform chronic care — if doctors and patients want it”

read at Endpoints ↗
88 words · retrieved 58m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cardiology3Heart Failure

related stories

  • 3h agoBMS says goodbye to 265 New Jersey staff as reorg rolls onBioSpace
  • Jul 31Novo setback casts doubt on a new way to treat heart diseaseBioPharma Dive
  • Jul 31Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%BioSpace
  • Jul 31Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 failFierce Biotech
  • Jul 29STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drugSTAT